Skip to main content

Table 1 Lung-molGPA

From: Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis

Prognostic

0

0.5

1.0

Age (y)

 ≥ 70

 < 70

NA

KPS

 < 70

80

90–100

ECM

Present

 

Absent

Brain metastases, No.

Gene status

 > 4

EGFR neg/unk and ALK neg/unk

1–4

NA

NA

EGFR pos or ALK pos

  1. GPA: graded prognostic assessment, ECM extracranial metastases, KPS Karnofsky Performance Status, NA not applicable, neg/unk negative or unknown, pos positive